OMCS
ACAD icon

Old Mutual Customised Solutions’s Acadia Pharmaceuticals ACAD Stock Holding History

Old Mutual Customised Solutions’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-1,300
Closed -$24K – 776
2013
Q2 		$24K Buy
+1,300
New +$17.9K 0.01% 1083

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return

Old Mutual Customised Solutions's ACAD Position: Q3 2013 in Review

Old Mutual Customised Solutions sold out of Acadia Pharmaceuticals (ACAD) in Q3 2013, closing a stake of 1,300 shares — an estimated $24K sold.

Old Mutual Customised Solutions first reported a position in ACAD in Q2 2013 and held it in 1 quarter. The position peaked at $24K in Q2 2013. 142 funds tracked by Wall St. Rank hold ACAD as of Q3 2013.

  • Old Mutual Customised Solutions reported no remaining Acadia Pharmaceuticals position as of Q3 2013 after selling out during the quarter.
  • Old Mutual Customised Solutions sold 1,300 Acadia Pharmaceuticals shares in Q3 2013, an estimated $24K.
  • Old Mutual Customised Solutions first reported a position in Acadia Pharmaceuticals in Q2 2013 and held it in 1 quarter.
  • Old Mutual Customised Solutions's Acadia Pharmaceuticals position peaked at $24K in Q2 2013.
  • 142 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2013.

Based on Old Mutual Customised Solutions's 13F filing for Q3 2013, filed 6 Nov 2013.